Search

everythinglearnresearchcommunity

for

Search:↓

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Monocytes might be linked to hair loss after COVID-19.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Many people with hair loss had low iron and ferritin levels.

MSC exosome therapy improved hair quality in patients with acquired trichorrhexis nodosa.

Antiepileptic drugs cause cosmetic side effects like hair loss and weight gain, but patients still take their medication without it affecting their quality of life.

PCOS requires personalized treatment to improve life quality and reduce health risks.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Scrotal rejuvenation treats aging-related changes in men's scrotum using methods like medication, hair transplantation, and surgery.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

Australian dermatologists often prescribe spironolactone and minoxidil for female hair loss.

Alcohol-free minoxidil is better for treating hair loss in Indian men.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Genes linked to wool fineness in sheep have been identified.

Australian dermatologists are updating their prescriptions for male pattern baldness.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.